CMS proposes 3.6% pay bump for docs, takes aim at chronic conditions in physician fee schedule

The Centers for Medicare & Medicaid Services (CMS) has proposed its 2026 physician fee schedule, including a 3.62% pay increase for physicians and a 3.83% increase for alternative payment models, signaling a continued shift towards data-informed, value-based care. Key reforms target the Medicare Shared Savings Program (MSSP) with adjusted ACO eligibility and quality metrics aimed at enhancing chronic disease management and efficiency. Notably, CMS seeks to reduce spending on skin substitutes by 90% through payment reclassification and introduces a new Ambulatory Specialty Model focused on prevention, underscoring a broad effort to modernize Medicare, cut waste, and improve patient outcomes.

Analysis

The Centers for Medicare & Medicaid Services (CMS) has released a proposed 2026 physician fee schedule that signals a dual strategy of increasing provider reimbursement while aggressively targeting cost inefficiencies. The proposal includes a 3.62% increase to the physician fee conversion factor and a 3.83% bump for alternative payment models, which directly addresses provider payment concerns and has been received favorably by primary care advocates. Concurrently, the rule introduces significant reforms aimed at cost containment, most notably a plan to reduce spending on skin substitutes by an estimated 90% by reclassifying them as "incident-to-supplies" rather than "biologicals," targeting a category where spending has surged from $252 million in 2019 to over $10 billion in 2024. Further structural changes include simplifying quality metrics for Accountable Care Organizations (ACOs) within the Medicare Shared Savings Program and introducing a new Ambulatory Specialty Model to promote preventative care for conditions like heart failure. These proposals, framed under the Trump administration's policy agenda, underscore a continued push toward value-based care by refining payment models to reward efficiency and outcomes while cutting specific areas of perceived waste.

Key Decisions for Investors

• Investors should immediately identify and review exposure to companies manufacturing or heavily marketing skin substitutes, as the proposed 90% payment reduction by CMS poses a direct and material threat to their revenue streams.
• The proposed reimbursement rate increases of 3.62% and 3.83% create a positive outlook for operators of physician groups and health systems with significant Medicare revenue, potentially improving margins in 2026.
• Consider opportunities in companies providing enabling technologies and services for value-based care, as the introduction of new models and refinements to the ACO program reinforces long-term support for data analytics and care coordination platforms.
• Monitor the regulatory process through the September comment deadline, as these are proposed rules that could be altered, and recognize that their implementation is tied to the prevailing political administration.